## HRL: Hormel Foods Corporation - XLP: Consumer Defensive

### Executive Summary

No thesis match: MRS_20 0.4% below STRENGTH zone (4.0-10.0%); PEG 3.39 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-3.9% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($22.65)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 2, Bearish: 0)

**1. Hormel Foods Named to Fast Company’s 2025 Brands That Matter List**
- Source: Perishable News | 20251209T180113 | Bullish | Relevance: 99%
-  Hormel Foods Corporation has been recognized on Fast Company’s 2025 Brands That Matter list for its impactful multi-brand, multi-channel marketing campaigns. The company's "Here for the Snacks" Big Game campaign successfully connected with consumers by positioning snacking as a key part of the event, showcasing the creativity of its marketing team. This honor highlights Hormel Foods' ability to engage audiences meaningfully and achieve real business impact.

**2. Rosen Law Firm Encourages Hormel Foods Corporation Investors to Inquire About Securities Class Action Investigation - HRL**
- Source: KWKT - FOX 44 | 20251209T012622 | Neutral | Relevance: 99%
-  Rosen Law Firm is investigating potential securities claims against Hormel Foods Corporation (HRL) following allegations that the company issued misleading business information. This probe comes after a Wall Street Journal article reported Hormel's reduced earnings forecast due to price pressures, bird flu, and a fire, which also led to a CFO change and a 9.1% stock drop. Investors who purchased Hormel securities are encouraged to contact the firm regarding their eligibility to join a prospective class action.

**3. Rosen Law Firm Encourages Hormel Foods Corporation Investors to Inquire About Securities Class Action Investigation - HRL**
- Source: WOWK 13 News | 20251209T012808 | Neutral | Relevance: 98%
-  The Rosen Law Firm is investigating a potential securities class action against Hormel Foods Corporation (NYSE: HRL) after allegations that Hormel may have issued materially misleading business information. This investigation follows a Wall Street Journal article from October 29, 2025, detailing how Hormel cut its forecast due to price pressures, bird flu, and a fire, causing a 9.1% stock drop. Investors who purchased Hormel securities are encouraged to contact the law firm to inquire about potential compensation.

**4. Meating a Milestone**
- Source: Hormel Foods | 20251210T190747 | Bullish | Relevance: 98%
-  Hormel Foods celebrates a significant milestone with 100 million SPAM® musubi units sold at FamilyMart in Japan since their 2021 introduction. Initially a limited-time offer, SPAM® musubi is now available in over 16,000 stores nationwide, highlighting the success of local adaptation and consumer understanding. This achievement underscores the SPAM® brand's global cultural impact and its effective expansion strategy in international markets.

**5. California Public Employees Retirement System Has $32.11 Million Holdings in Hormel Foods Corporation $HRL**
- Source: MarketBeat | 20251211T093820 | Neutral | Relevance: 97%
-  The California Public Employees Retirement System reduced its stake in Hormel Foods Corporation (NYSE:HRL) by 17.4% in the second quarter, now holding 1,061,354 shares worth $32.11 million. Despite this reduction, other institutional investors have increased their holdings. Hormel Foods recently reported quarterly earnings that topped analyst estimates and announced an increase in its quarterly dividend.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 3, Lowers: 2)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-09 | Barclays | $30 | $31 | -3% |
| 2025-12-05 | Piper Sandler | $26 | $25 | +4% |
| 2025-12-05 | JP Morgan | $28 | $27 | +4% |
| 2025-12-05 | B of A Securiti | $26 | $25 | +4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-09 | Barclays | main | Overweight |
| 2025-12-05 | Piper Sandler | main | Neutral |
| 2025-12-05 | JP Morgan | main | Overweight |
| 2025-12-05 | B of A Securiti | main | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 4 ($0.26M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 24.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 10 / 0 |

**Top Holders:**
- Vanguard Group Inc: 6.8% (+2.0%)
- State Street Corpora: 5.1% (+1.0%)
- Blackrock Inc.: 4.6% (+2.2%)
- Invesco Ltd.: 2.1% (+66.5%)
- Geode Capital Manage: 1.5% (+1.7%)

### Key Risks

1. Valuation risk: PEG 3.4x with declining EPS estimates leaves no margin for error.
2. Long-term trend broken: trading 13.9% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Analyst target momentum: 3 raises (avg +4%) could attract flows.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 3.39 signals overvaluation risk, limited margin of safety. Balance sheet: strong liquidity (2.5x), low leverage (D/E 0.18). Institutional flow bullish (10 buying vs 0 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $13.0B |
| Beta | 0.33 |
| 52W Range | $21.03 - $33.32 |
| Short Interest | 5.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.39 |
| Forward P/E | 15.2 |
| Current P/E | 16.4 |
| YoY Growth | 8.0% |
| EPS Direction | FALLING |

### Technicals

MRS_20 deteriorating from 4.3% to 0.4% (-3.9% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 3.6pp (needs >4.0% for momentum thesis). MRS_5 (-0.6%) diverging from MRS_20 - short-term weakness emerging. Below SMA200 (0.86x), long-term trend not supportive. RSI neutral at 57.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 0.43% (CS: 48) | Neutral |
| RSI_14 | 57.4 | Neutral |
| MACD Histogram | 0.12 | Bullish |
| vs SMA20 | 1.026x | Above |
| vs SMA50 | 1.025x | Above |
| vs SMA200 | 0.861x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $23.71
- **Stop Loss:** $22.65 (4.5% risk)
- **Target:** $24.77 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 1301
- **Position Value:** $30,846.71
- **Portfolio %:** 30.85%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | IGNITION (Zone D) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-02-26 (Est: $0.32)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $0.30 | $0.32 | +6.0% |
| 2025Q3 | $0.41 | $0.35 | -14.5% |
| 2025Q2 | $0.34 | $0.35 | +3.3% |
| 2025Q1 | $0.37 | $0.35 | -6.6% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*